Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06226103
Other study ID # REC-45/06/919
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 7, 2023
Est. completion date October 30, 2023

Study information

Verified date January 2024
Source University of Jazan
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: Ageing is frequently accompanied by physiological changes that might result in a deterioration in physical and cognitive abilities, which frequently leads to institutionalization or the loss of autonomy. Mild cognitive impairment (MCI) is an intermediate state between normal cognitive aging and early dementia, the optimal period to intervene with preventive strategies and early treatments. Thus, the current study intends to investigate the effects of aerobic and computer-based cognitive training on age-related cognitive decline. Methods: This is a single-blinded, randomized controlled trial. Elderly patients with mild cognitive impairment (n = 60) will be randomized to 2 arms and treated for 12 weeks: arm 1 (aerobic exercise and computerized cognitive training) and arm 2 (Placebo; will not receive any intervention). Outcome measure used were Montreal Cognitive Assessment (MOCA) test, Barthel Index (BI) and short form survey-12 (SF-12). Statistical Analysis: To compare the baseline characteristics and outcome variables between the two groups, independent t-tests was employed. A two-way repeated measures ANOVA was utilized to determine the interaction effect of time (baseline, post-treatment, and follow-up) and group (intervention vs. control) on the outcome measures.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date October 30, 2023
Est. primary completion date September 15, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 60 Years to 85 Years
Eligibility Inclusion Criteria: - Who fulfilled MCI criteria [10]: (1) subjective cognitive concerns; (2) objective cognitive impairment in memory, executive function, attention, and/or language; (3) preserved activities of daily living; and (4) absence of dementia - Literate - Had adequate visual, auditory, and fine motor skills. Exclusion Criteria: - Major depression (scored > 9 in the Geriatric Depression Scale, GDS-15) [11] - Schizophrenia - Substance abuse - parkinsonism - conditions affecting gait (eg, severe osteoarthritis, previous stroke), - participated in any cognitive training program during last 6 months > 2 h/week - ACSM contraindications to exercise or other factors that make exercise impossible or unsafe - cognitive enhancers, or anticholinergics

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Aerobic Exercise and Computerized Cognitive Training
Aerobic Exercise (AE) included walk briskly, increasing intensity and duration progressively. The first week they had to walk 30 min per day, 3 days per week, up to 9-10 on the Borg Rating of Perceived Exertion Scale (BRPES; Borg, 1982) perceived as light intensity; during the second week, the duration was increased to 45 min and the intensity 9-10 and frequency (3 days per week) were maintained; the following 10 weeks they maintained the duration (45 min) and frequency (3 days per week) and increased the intensity up to 12-14 on BRPES perceived as moderate-high effort. Computerized Cognitive Training (CCT) included a multidomain computer-based cognitive training using the brainHQ software in sessions of 45 min, 3 days per week for 12 weeks. Cognitive tasks targeted attention, recognition, colour and shape, identification, calculation, visual perception, visual spatial processing, memory, and executive function.
Conventional Exercises and Brain health lectures
Participants were exposed to balancing, coordination, stretching, and core exercises. Additionally, they attended brain health lectures to provide a comparative non-interactive cognitive engagement. Both the exercises and lectures were scheduled similar to the intervention group over 12 weeks

Locations

Country Name City State
Saudi Arabia Jazan University Jazan

Sponsors (1)

Lead Sponsor Collaborator
University of Jazan

Country where clinical trial is conducted

Saudi Arabia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Montreal Cognitive Assessment test A commonly used test to assess different cognitive domains, including short-term memory recall, visuospatial abilities, executive functions, attention, concentration, and working memory. MoCA scores range between 0 and 30 where the highest score is considered to be normal. at the baseline (day 0), at the end of the treatment (after 12 weeks) as well as after 4 weeks of follow up (after 16 weeks)
Primary Barthel Index This index was used to measure an individual's capacity to perform ten activities of daily living, reflecting their functional independence. Total possible scores range from 0 - 20, with lower scores indicating increased disability. at the baseline (day 0), at the end of the treatment (after 12 weeks) as well as after 4 weeks of follow up (after 16 weeks)
Primary Short form survey-12 A generic measure utilized to assess the health-related quality of life, covering both physical and mental health dimensions. The summary scores range from a minimum of 0 to a maximum of 100. Higher the SF-12 scores, indicates the higher (better) quality of life. at the baseline (day 0), at the end of the treatment (after 12 weeks) as well as after 4 weeks of follow up (after 16 weeks)
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04121728 - Modulation of Attention in Event Related Potential (ERPs) as a Marker of Early Cognitive Decline by Ginkgo Biloba N/A
Enrolling by invitation NCT04641663 - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST) N/A
Completed NCT03228446 - The Effects of Attentional Filter Training on Working Memory N/A
Completed NCT04910399 - Development of an Innovative Health Ingredient From Marine By-products for the Healthy Aging N/A
Recruiting NCT03275363 - The University of Hong Kong Neurocognitive Disorder Cohort N/A
Completed NCT02185222 - Effect of Vitamin D on Cognitive Decline of Patients With Memory Complaint Phase 3
Completed NCT03162913 - The Effects of Strawberry Supplementation on Memory and Gait Among Over-weight Older Adults N/A
Completed NCT02416401 - Attention Training for Learning Enhancement and Resilience Trial N/A
Completed NCT02922920 - Effects of Tart Cherry Juice on the Body N/A
Completed NCT01120860 - Magnetic Resonance Imaging (MRI) and Decline of Aging Aviator Performance N/A
Recruiting NCT03702335 - Impact of Comprehensive Dietary Counseling on Dietary Quality, Mental Health, and Quality of Life in Older Adults N/A
Completed NCT05828043 - Brain Aging: Muscle-to-brain Axis Modulates Physio-cognitive Decline N/A
Active, not recruiting NCT05348694 - OsteoPreP: Food Supplements for Postmenopausal Bone Health Phase 4
Recruiting NCT05194787 - TAS Test: Online Motor-cognitive Tests for Early Detection of Alzheimer's Disease
Recruiting NCT04184375 - Cognitive Stimulation for Elderly Bipolar Patients N/A
Recruiting NCT04171323 - The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia N/A
Not yet recruiting NCT06248723 - ItaliaN Study With Tailored Multidomain Interventions to Prevent Functional and Cognitive Decline in Community-dwelling Older Adults N/A
Terminated NCT04732312 - Impact of Formal Home Help on Quality of Life for Caregivers of Elderly Patients With Neurocognitive Impairment
Recruiting NCT06377254 - Multi-organ Responses to CHronic Physical Activity and INactivity N/A
Not yet recruiting NCT04566757 - Safety and Efficacy of Human Umbilical Cord Blood Plasma Infusion for Age-Related Cognitive Decline Phase 1